S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
GOOGL   1,182.56 (-0.05%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
GOOGL   1,182.56 (-0.05%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
GOOGL   1,182.56 (-0.05%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
GOOGL   1,182.56 (-0.05%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
Log in

NASDAQ:KURAKura Oncology SEC Filings & 10K Form

$8.23
-0.47 (-5.40 %)
(As of 04/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.18
Now: $8.23
$9.09
50-Day Range
$6.45
MA: $10.14
$12.60
52-Week Range
$6.35
Now: $8.23
$21.42
Volume384,400 shs
Average Volume346,734 shs
Market Capitalization$373.87 million
P/E RatioN/A
Dividend YieldN/A
Beta2.05

SEC Filings

Kura Oncology (NASDAQ:KURA) SEC Filings

DateFilerForm TypeView
03/17/2020
7:19 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
10:46 AM
Kura Oncology (Filer)
Form CT ORDER
03/17/2020
10:43 AM
Kura Oncology (Filer)
Form CT ORDER
03/17/2020
10:39 AM
Kura Oncology (Filer)
Form CT ORDER
03/16/2020
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G
02/14/2020
3:20 PM
GREAT POINT PARTNERS LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/14/2020
1:31 PM
EcoR1 Capital, LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/12/2020
3:24 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
11:16 AM
BlackRock Inc. (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
01/31/2020
10:31 AM
Kura Oncology (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G
01/23/2020
3:36 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:00 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:05 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:10 PM
FLOWERS KIRSTEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
3:09 PM
FLOWERS KIRSTEN (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2019
9:39 AM
EAGLE ASSET MANAGEMENT INC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
12/16/2019
6:36 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
6:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
4:23 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
4:23 PM
BASTA JAMES (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2019
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
8:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:07 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
3:06 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2019
7:00 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
7:02 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
11:15 PM
Kura Oncology (Filer)
Form EFFECT
08/28/2019
4:29 PM
Kura Oncology (Filer)
Form 424B3
08/21/2019
3:07 PM
Kura Oncology (Filer)
Form S-3/A
08/13/2019
5:17 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
5:16 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2019
3:12 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:37 PM
Kura Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/01/2019
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2019
3:04 PM
GUALBERTO ANTONIO (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
1:58 PM
FMR LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
06/27/2019
3:10 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:09 PM
Kura Oncology (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:07 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:06 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:05 PM
HOFFMAN ROBERT (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:01 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:03 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:02 PM
Kura Oncology (Filer)
Form 424B5
06/18/2019
3:03 PM
Kura Oncology (Filer)
Form 424B5
06/14/2019
6:12 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2019
3:04 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:22 PM
Kura Oncology (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
2:21 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/14/2019
2:10 PM
ARCH Venture Fund VIII, L.P. (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
01/30/2019
3:23 PM
Kura Oncology (Subject)
WILSON TROY EDWARD (Filed by)
Form SC 13G/A
01/24/2019
3:13 PM
Kura Oncology (Issuer)
REN PINGDA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:11 PM
Kura Oncology (Issuer)
North Annette (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:10 PM
FARNAM JOHN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:08 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:07 PM
GUALBERTO ANTONIO (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:06 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
3:16 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/15/2019
3:09 PM
EAGLE ASSET MANAGEMENT INC (Filed by)
Kura Oncology (Subject)
Form SC 13G
01/10/2019
5:32 PM
EcoR1 Capital Fund Qualified, L.P. (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:30 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
5:26 PM
EcoR1 Capital Fund Qualified, L.P. (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
6:14 PM
EcoR1 Capital Fund Qualified, L.P. (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
7:30 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2018
3:03 PM
Kura Oncology (Filer)
Form 424B3
11/22/2018
11:15 PM
Kura Oncology (Filer)
Form EFFECT
11/09/2018
3:03 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
1:18 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
1:15 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2018
7:30 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
5:18 PM
EcoR1 Capital Fund Qualified, L.P. (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2018
3:22 PM
Kura Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/05/2018
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:50 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
3:12 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
3:11 PM
GRASSO MARC (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2018
3:16 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2018
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
3:05 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2018
9:52 AM
FMR LLC (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
07/09/2018
4:05 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G
07/03/2018
4:07 PM
FARNAM JOHN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
4:06 PM
FARNAM JOHN (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2018
4:00 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
3:53 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
3:51 PM
Kura Oncology (Filer)
Form 424B5
06/27/2018
8:47 PM
Kura Oncology (Filer)
Form S-3MEF
06/27/2018
3:02 PM
Kura Oncology (Filer)
Form 424B5
06/20/2018
7:00 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
3:05 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
3:10 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
3:09 PM
HOFFMAN ROBERT (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
3:06 PM
Kura Oncology (Filer)
Form DEFA14A
04/26/2018
3:05 PM
Kura Oncology (Filer)
Form DEF 14A
04/26/2018
10:44 AM
Kura Oncology (Filer)
Form CT ORDER
03/12/2018
3:26 PM
Kura Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2018
3:20 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: Buy Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel